Manor Royal business Chemigraphic receives £7m private equity investment
Manor Royal based Chemigraphic, the leading provider of Electronic Manufacturing Services (EMS) to the fast-growth medical technology, defence and power systems sectors, has announced that it has received £7 million investment from NVM Private Equity (NVM), from its Vintage III fund.
The investment will help to accelerate Chemigraphic's international growth and drive continued development of its technology and expertise, particularly in the fast-growing med-tech sector.
Headquartered in Manor Royal, with a sourcing office in China, Chemigraphic builds complex products for a wide range of specialist UK and global technology brands, from conception to production, supporting them at every stage of their product lifecycle. Chemigraphic CEO Chris Wootton, who joined the business in April 2017, has a clear vision to scale the business globally and has a strong track record of creating value for his shareholders throughout his career.
With over 150 staff and experience spanning over four decades, Chemigraphic is now set for a period of strong growth, which has been boosted further by the NVM investment. Chemigraphic's customers, many of whom have worked with the business for over 15 years, trust them to be involved in the very early stages of new product development for their most complex products, followed by ongoing fulfilment of production.
NVM Private Equity is independently owned with over 30 years' experience of investing in unquoted UK businesses. NVM is a generalist investor, managing approximately £430 million of funds, and is differentiated by having executives living and working in regional business communities throughout the UK. Peter Hodson and David Rolfe led the investment for NVM and Peter joined the Chemigraphic board upon completion.